Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 166

    1.

    Narrative review: the promotion of gabapentin: an analysis of internal industry documents.

    Steinman MA, Bero LA, Chren MM, Landefeld CS.

    Ann Intern Med. 2006 Aug 15;145(4):284-93. Review.PMID: 16908919 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The ADVANTAGE seeding trial: a review of internal documents.

    Hill KP, Ross JS, Egilman DS, Krumholz HM.

    Ann Intern Med. 2008 Aug 19;149(4):251-8. Review.PMID: 18711155 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.

    Ross JS, Hill KP, Egilman DS, Krumholz HM.

    JAMA. 2008 Apr 16;299(15):1800-12.PMID: 18413874 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Characteristics and impact of drug detailing for gabapentin.

    Steinman MA, Harper GM, Chren MM, Landefeld CS, Bero LA.

    PLoS Med. 2007 Apr;4(4):e134.PMID: 17455990 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Drug maker to pay $430 million in fines, civil damages.

    [No authors listed]

    FDA Consum. 2004 Jul-Aug;38(4):36-7.PMID: 15346583 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The promotion of gabapentin.

    Sapers BL.

    Ann Intern Med. 2007 Feb 20;146(4):313; author reply 313-4. No abstract available. PMID: 17310059 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The promotion of gabapentin.

    Finucane TE.

    Ann Intern Med. 2007 Feb 20;146(4):312-3; author reply 313-4. No abstract available. PMID: 17310057 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Examination of the evidence for off-label use of gabapentin.

    Mack A.

    J Manag Care Pharm. 2003 Nov-Dec;9(6):559-68. Review.PMID: 14664664 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The promotion of gabapentin.

    Peterson ED, Boyce K, Overstreet K.

    Ann Intern Med. 2007 Feb 20;146(4):313; author reply 313-4. No abstract available. PMID: 17310060 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Disseminating findings from a drug class review: using best practices to inform prescription of antiepileptic drugs for bipolar disorder.

    Melvin CL, Ranney LM, Carey TS, Evans WD, AED Dissemination Panel, Kreps G, Linden T, Oldham J.

    J Psychiatr Pract. 2008 Mar;14 Suppl 1:44-56. Erratum in: J Psychiatr Pract. 2008 May;14(3):193. PMID: 19034209 [PubMed - indexed for MEDLINE]Related articles

    11.

    Patterns of prescribing antiepileptic drugs for bipolar disorder.

    Kish-Doto J, Evans WD, Squire C, Williams P, Ranney LM, Melvin CL.

    J Psychiatr Pract. 2008 Mar;14 Suppl 1:35-43. Erratum in: J Psychiatr Pract. 2008 May;14(3):193. PMID: 19034208 [PubMed - indexed for MEDLINE]Related articles

    12.

    Outcome reporting in industry-sponsored trials of gabapentin for off-label use.

    Vedula SS, Bero L, Scherer RW, Dickersin K.

    N Engl J Med. 2009 Nov 12;361(20):1963-71.PMID: 19907043 [PubMed - in process]Related articles

    14.

    A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998.

    Ma J, Stafford RS, Cockburn IM, Finkelstein SN.

    Clin Ther. 2003 May;25(5):1503-17.PMID: 12867225 [PubMed - indexed for MEDLINE]Related articles

    15.

    Continuing education for general practice and the role of the pharmaceutical industry.

    Hayes TM, Allery LA, Harding KG, Owen PA.

    Br J Gen Pract. 1990 Dec;40(341):510-2.PMID: 2282231 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Role of gabapentin in the treatment of uremic pruritus.

    Vila T, Gommer J, Scates AC.

    Ann Pharmacother. 2008 Jul;42(7):1080-4. Epub 2008 May 20.PMID: 18492782 [PubMed - indexed for MEDLINE]Related articles

    17.

    Warner-Lambert found guilty of promoting neurontin off label.

    Larkin M.

    Lancet Neurol. 2004 Jul;3(7):387. No abstract available. PMID: 15228033 [PubMed - indexed for MEDLINE]Related articles

    18.

    The promotion of olanzapine in primary care: an examination of internal industry documents.

    Spielmans GI.

    Soc Sci Med. 2009 Jul;69(1):14-20. Epub 2009 May 27.PMID: 19481322 [PubMed - indexed for MEDLINE]Related articles

    19.

    Ghosts in the machine: publication planning in the medical sciences.

    Sismondo S.

    Soc Stud Sci. 2009 Apr;39(2):171-98.PMID: 19831220 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)]

    Pinheiro D.

    Encephale. 2008 Sep;34(4):409-15. Epub 2008 Jan 14. Review. French. PMID: 18922244 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data